Facebook
Twitter
LinkedIn
Forward2018 Winter Milwaukee Conference: Updates and Advances in Managing and Treating Cancer
The goal of this conference is to provide a forum to discuss, inform and educate pharmacy and nursing practitioners with evidence-based updates on the management and treatment of patients with cancer, and to create an opportunity for networking among the members of the health care team.
Learning Objectives
As a result of participating in this conference, learners should be able to:
1) Discuss new therapies for the treatment of leukemia.
2) Summarize new treatments, including target therapies, for colorectal cancer that can extend patient life expectancy and improve overall quality of life.
3) Describe strategies for treating lung cancer, to include new oral and immunotherapy treatment options.
4) Identify the desired outcomes of new therapies to treat breast cancer.
5) Discuss the role of the health care team in managing the side effects of cancer chemotherapy.
6) Define biosimilars and discuss their role in treating patients with cancer.
Additional Information
| Attachment | Size |
|---|---|
 2018 Winter Milwaukee Conference agenda.docx | 39.7 KB |
Ruth Bruskiewitz, MS, RPh
Clinical Professor
Division of Pharmacy Professional Development
University of Wisconsin-Madison School of Pharmacy
Madison, Wisconsin
Felicia Zook, PharmD, BCOP
Clinical Oncology Pharmacist
Froedtert and the Medical College of Wisconsin
Milwaukee, Wisconsin
Elizabeth Dow, PharmD, BCPS, BCOP
Clinical Pharmacist, Hematology/Oncology
UW Health
University of Wisconsin Hospitals and Clinics
Madison, Wisconsin
Carolyn Oxencis, PharmD, BCPS, BCOP
Clinical Assistant Professor
Department of Clinical Sciences
Medical College of Wisconsin School of Pharmacy
Clinical Oncology Pharmacist
Froedtert and the Medical College of Wisconsin
Milwaukee, Wisconsin
Sarah Lentz, RPh, BCOP
Senior Clinical Pharmacist
UW Health
University of Wisconsin Hospitals and Clinics
Madison, Wisconsin
Sol Atienza, PharmD, BCOP
Pharmacy Specialty Coordinator - Oncology
Director, Pharmacy Oncology Residency
Aurora Health Care
Aurora St. Luke’s Medical Center
Milwaukee, Wisconsin
Jennifer Piccolo, PharmD, BCOP
Clinical Hematology/Oncology Pharmacist
UW Health
University of Wisconsin Hospital and Clinics
Madison, Wisconsin
Ruth Bruskiewitz, MS, RPh
Clinical Professor
Division of Pharmacy Professional Development
University of Wisconsin-Madison School of Pharmacy
Madison, Wisconsin
In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Accreditation Council for Pharmacy Education (ACPE) Credit Statement
6.0 hours of knowledge-based CE credit can be earned by successfully completing this activity. CE credit information, based on verification of live attendance and completion of the program assessment and online evaluation, will be submitted electronically to NABP within 60 days after the activity completion.
UAN: JA0000358-0000-18-005-L01-P 6 hours (0.6 CEUs)
American Nurses Credentialing Center (ANCC) & Iowa Board of Nursing Credit Statement
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 6.0 ANCC and Iowa contact hours. (ANCC pharmacotherapeutic contact hours will be calculated and awarded as appropriate to meet the needs of advanced practice nurses.)
The University of Wisconsin-Madison School of Nursing is Iowa Board of Nursing provider 350. A copy of the evaluation(s) may be sent to the Iowa Board of Nursing, 400 SW 8th St., Suite B, Des Moines, IA 50309.
Available Credit
- 6.00 ACPE Contact Hours - Pharmacist
- 6.00 ANCC Contact Hours
- 6.00 Iowa Board of Nursing Contact Hours
- 6.00 University of Wisconsin–Madison Continuing Education Hours